Point72 Hong Kong’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,360
Closed -$167K 1249
2022
Q3
$167K Buy
3,360
+2,847
+555% +$158K 0.01% 1097
2022
Q2
$30K Sell
513
-938
-65% -$51.7K ﹤0.01% 1472
2022
Q1
$77K Sell
1,451
-228
-14% -$13.2K ﹤0.01% 1220
2021
Q4
$102K Buy
1,679
+1,586
+1,705% +$94.2K ﹤0.01% 1172
2021
Q3
$5K Buy
+93
New +$5.11K ﹤0.01% 1842
2021
Q2
Sell
-930
Closed -$41K 2257
2021
Q1
$41K Buy
930
+605
+186% +$25.4K ﹤0.01% 1322
2020
Q4
$11K Buy
+325
New +$11.5K ﹤0.01% 1525
2020
Q1
Sell
-3,858
Closed -$156K 1253
2019
Q4
$156K Buy
3,858
+3,591
+1,345% +$134K 0.04% 401
2019
Q3
$9K Buy
+267
New +$8.79K ﹤0.01% 771
2018
Q4
Sell
-631
Closed -$24K 1129
2018
Q3
$24K Buy
+631
New +$23.9K 0.01% 576
2017
Q4
Sell
-190
Closed -$10K 1026
2017
Q3
$10K Sell
190
-1,255
-87% -$64.1K 0.01% 487
2017
Q2
$76K Buy
1,445
+827
+134% +$44.3K 0.08% 148
2017
Q1
$34K Buy
+618
New +$34.1K 0.04% 313
2016
Q4
Sell
-2,600
Closed -$126K 997
2016
Q3
$126K Buy
+2,600
New +$131K 0.07% 309

Other funds holding PBH

Point72 Hong Kong's PBH Position: Q4 2022 in Review

Point72 Hong Kong sold out of Prestige Consumer Healthcare (PBH) in Q4 2022, closing a stake of 3,360 shares — an estimated $167K sold.

Point72 Hong Kong first reported a position in PBH in Q3 2016 and held it in 14 quarters. The position peaked at $167K in Q3 2022. 289 funds tracked by Wall St. Rank hold PBH as of Q4 2022.

  • Point72 Hong Kong reported no remaining Prestige Consumer Healthcare position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 3,360 Prestige Consumer Healthcare shares in Q4 2022, an estimated $167K.
  • Point72 Hong Kong first reported a position in Prestige Consumer Healthcare in Q3 2016 and held it in 14 quarters.
  • Point72 Hong Kong's Prestige Consumer Healthcare position peaked at $167K in Q3 2022.
  • 289 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.